Prescribing hormone replacement therapy: key considerations for primary care physicians
- PMID: 37385757
- PMCID: PMC10325598
- DOI: 10.3399/bjgp23X733473
Prescribing hormone replacement therapy: key considerations for primary care physicians
Erratum in
-
Correction.Br J Gen Pract. 2023 Jul 27;73(733):347. doi: 10.3399/bjgp23X734493. Print 2023 Aug. Br J Gen Pract. 2023. PMID: 37500473 Free PMC article. No abstract available.
Conflict of interest statement
Rima Chakrabarti is a member of the British Menopause Society (BMS).
Figures
Comment in
-
Prescribing hormone replacement therapy: key considerations for primary care physicians.Br J Gen Pract. 2023 Jul 27;73(733):346. doi: 10.3399/bjgp23X734445. Print 2023 Aug. Br J Gen Pract. 2023. PMID: 37500474 Free PMC article. No abstract available.
References
-
- Quinn H. HRT prescriptions double in five years, despite supply shortages. Pharmaceutical Journal. 2022. Mar 17, https://pharmaceutical-journal.com/article/news/hrt-prescriptions-more-t... (accessed 18 Apr 2023).
-
- Harper-Harrison G, Shanahan MM. Hormone replacement therapy. StatPearls. 2023. Feb 20, https://www.ncbi.nlm.nih.gov/books/NBK493191/ (accessed 18 Apr 2023). - PubMed
-
- British Menopause Society BMS & WHC’s 2020 recommendations on hormone replacement therapy in menopausal women. 2021. https://thebms.org.uk/publications/consensus-statements/bms-whcs-2020-re... (accessed 18 Apr 2023). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources